TD SYNNEX Other Non-Current Liabilities increased by 3.2% to $462.36M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.0%, from $462.55M to $462.36M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 28.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $131.10M | $130.92M | $556.13M | $514.94M | $479.74M | $496.04M | $501.86M | $528.84M | $538.86M | $505.20M | $498.66M | $493.03M | $455.30M | $450.36M | $468.65M | $462.55M | $487.23M | $463.90M | $447.98M | $462.36M |
| QoQ Change | — | -0.1% | +324.8% | -7.4% | -6.8% | +3.4% | +1.2% | +5.4% | +1.9% | -6.2% | -1.3% | -1.1% | -7.7% | -1.1% | +4.1% | -1.3% | +5.3% | -4.8% | -3.4% | +3.2% |
| YoY Change | — | — | — | — | +265.9% | +278.9% | -9.8% | +2.7% | +12.3% | +1.8% | -0.6% | -6.8% | -15.5% | -10.9% | -6.0% | -6.2% | +7.0% | +3.0% | -4.4% | -0.0% |